Skip to main navigation Skip to search Skip to main content

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

David Cohen, Timothy Maughan, Gareth O. Griffiths, Sarah Burns, Simon Noble, Fergus Macbeth

Research output: Contribution to journal › Article › peer-review

87 Downloads (Pure)

Fingerprint

Dive into the research topics of 'FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science